皮膚科藥物市場：按藥物類別、用途- 2023-2030 年全球預測

預計2023年全球皮膚科治療市場將達569.9億美元，年複合成長率為10.31%，預計2030年將達到1137.9億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球皮膚科治療市場至關重要。透過檢視業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使用戶能夠根據自己的具體需求做出資訊的決策。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球皮膚科用藥市場規模及預測如何？

2.在預測期內，COVID-19對全球皮膚科治療市場的阻礙因素與影響有哪些？

3. 在預測期內，全球皮膚科治療市場需要投資哪些產品/細分市場/用途/領域？

4.全球皮膚科用藥市場的競爭策略為何？

5. 全球皮膚病治療市場的技術趨勢和法律規範是什麼？

6.全球皮膚科治療市場主要廠商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入全球皮膚科藥物市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 皮膚病罹患率增加
    • 醫療費用不斷上漲，人們對皮膚病的認知不斷提高
    • 對順勢療法皮膚病治療的需求不斷成長
  • 抑制因素
    • 皮膚科治療費用相對較高
  • 機會
    • 開發下一代皮膚癌治療方法
    • 醫用皮膚科藥物研發與技術創新
  • 任務
    • 某些類型藥物的副作用
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 皮膚科治療藥物市場：依藥物類別

• 介紹
• 痤瘡對策
• 感染疾病
• 鈣調磷酸酶抑制劑
• 皮質類固醇
• 類維生素A

第7章 皮膚科治療藥物市場：依用途

• 介紹
• 脫髮症
• 異位性皮膚炎
• 皰疹
• 銀屑病
• 酒糟樣皮膚炎

第8章 北美和南美皮膚科藥物市場

• 介紹
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第9章 亞太皮膚科治療藥物市場

• 介紹
• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第10章 歐洲、中東和非洲皮膚科藥品市場

• 介紹
• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第11章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

• 討論指南
• 關於許可證和定價

The Global Dermatological Therapeutics Market is forecasted to grow significantly, with a projected USD 56.99 billion in 2023 at a CAGR of 10.31% and expected to reach a staggering USD 113.79 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Dermatological Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Dermatological Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Class, market is studied across Anti-Acne, Anti-Infectives, Calcineurin Inhibitors, Corticosteroids, and Retinoids. The Calcineurin Inhibitors is projected to witness significant market share during forecast period.

Based on Application, market is studied across Alopecia, Atopic Dermatitis, Herpes, Psoriasis, and Rosacea. The Herpes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Dermatological Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Dermatological Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Dermatological Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Dermatological Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Dermatological Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Dermatological Therapeutics Market?

6. What is the market share of the leading vendors in the Global Dermatological Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Dermatological Therapeutics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Dermatological Therapeutics Market, by Drug Class, 2022 vs 2030
• 4.3. Dermatological Therapeutics Market, by Application, 2022 vs 2030
• 4.4. Dermatological Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalences of the skin disorders
    • 5.1.1.2. Increasing healthcare expenditure and growing awareness about skin diseases
    • 5.1.1.3. Rising demand for homeopathy dermatology therapeutics
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively high cost of the dermatology therapeutics
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of next-generation therapeutics for skin cancer
    • 5.1.3.2. Medical dermatology therapeutic R&D and technical innovation
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects for certain classes of therapeutic drugs
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Dermatological Therapeutics Market, by Drug Class

• 6.1. Introduction
• 6.2. Anti-Acne
• 6.3. Anti-Infectives
• 6.4. Calcineurin Inhibitors
• 6.5. Corticosteroids
• 6.6. Retinoids

7. Dermatological Therapeutics Market, by Application

• 7.1. Introduction
• 7.2. Alopecia
• 7.3. Atopic Dermatitis
• 7.4. Herpes
• 7.5. Psoriasis
• 7.6. Rosacea

8. Americas Dermatological Therapeutics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Dermatological Therapeutics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Dermatological Therapeutics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2022 VS 2030
• FIGURE 3. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
• FIGURE 5. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. DERMATOLOGICAL THERAPEUTICS MARKET DYNAMICS
• FIGURE 8. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. DERMATOLOGICAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. DERMATOLOGICAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. DERMATOLOGICAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 5. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ANTI-ACNE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY HERPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ROSACEA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. CANADA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 24. CANADA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CHINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 36. CHINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. INDIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 38. INDIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. ITALY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 73. ITALY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. POLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 81. POLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. QATAR DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 83. QATAR DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. DERMATOLOGICAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 103. DERMATOLOGICAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 104. DERMATOLOGICAL THERAPEUTICS MARKET LICENSE & PRICING